A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of LRK-4189 Alone and in Combination in Patients With Solid Tumors
Clinical trial NCT07498725 · RECRUITING
Trial details
- NCT number
- NCT07498725
- Sponsor
- LARKSPUR BIOSCIENCES, INC.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-07
- Primary completion
- 2029-06-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.